Department of Health
MEDICINES CONTROL AGENCY
Market Towers 1 Nine Elms Lane London SW8 5NQ
Telephone 0171-273 0270
Facsimile 0171- 273 0293
From the Office of the Chief Executive 6 February 1998

Dear Charles

Thank you for your further letter of 16 January regarding your paper "The Antidepressant Web".

You appear to be under the impression that we are proposing a formal public consultation exercise but this is not the case. We are seeking the views of a wide range of expert advisers and other relevant bodies and are asking for:

(1) their perspective on the issues you have raised; and

(2) any information they have which is relevant to these matters

to inform the review I mentioned in my previous letter.

It is our normal policy for such correspondence to be treated as confidential (though I have advised you above of what we are asking for) because this is part of the process of deliberation and advice covered by Exemption 2 of Part II of the Code of Practice on Access to Government Information. Disclosure of the replies we receive would harm the frankness and candour of advice and opinions given.

I will let you have an update on developments in due course and what further action, if any, we propose.

With regard to the abstract you cite, we do not hold a record of when the MCA first received the article. Dr Wood has already commented on the abstract in her letter dated 23 January and there is nothing further I can add.

If you have a query about this letter, please contact me. If you are unhappy with my decision, you may ask for it to be reviewed. If you wish to ask for a review, you should write to me in the first instance. After that, if you are still unhappy, you may ask a Member of Parliament to make a complaint on your behalf to the Ombudsman (known officially as the Parliamentary Commissioner for Administration) who will decide whether or not to conduct his own enquiry.

Yours sincerely

Dr Keith Jones
Chief Executive

CLICK HERE TO READ ON

Contents page
List of MCA/CSM Correspondence